Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Genomic Instability × alectinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 7 Neoplasms 2 Lung Neoplasms 2 Multiple Endocrine Neoplasia Type 2a 1 Genomic Instability 1 Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer 1

Interventions

atezolizumab 1 alectinib 1 Vemurafenib 1 Neoadjuvant Therapy 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02314481 2025-05-23

DARWINII

University College, London

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Genomic Instability

Data powered by HemOnc (CC BY 4.0) Colophon ⚡